GOLDBERG MORTON 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Nov 13, 2019
Insider Transaction Report
Form 4
GOLDBERG MORTON
Director
Transactions
- Sale
Common Stock
2019-11-12$4.29/sh−2,001$8,584→ 1,961 total
Footnotes (1)
- [F1]Effective as of 08/30/2019, the Issuer effected a 1-for-15 reverse split of its common stock. The number of shares reflects the reverse stock split.